Roche’s Tecentriq Glows In Pivotal Trial For Early Lung Cancer

Immunotherapy Improves DFS In Early NSCLC

 
• By Sten Stovall
IMPower010 Met Its Endpoint of Disease-Free Survival At Interim Analysis • Source: Shutterstock

More from Clinical Trials

More from R&D